Incidence increased monotonically with CKD severity from 0.29 per 100 person-years in G1 to 6.93 in G5 (G2: 1.16, G3a: 1.76, G3b: 3.14, G4: 4.46), with a highly significant trend ( p -trend < 0.001).
← all excerpts
Incidence of new-onset HFpEF across CKD stages and Its association with cardio-renal, inflammatory, and fibrotic biomarkers.
1
—
—